Profile
| Role | Insider |
|---|---|
| Notability | 20/100 |
Board memberships
- Athira Pharma, Inc.
Updated Jul 16, 2026
Renninger Robert is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $6K.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-06 | LONA | LeonaBio, Inc. | S — Open-market sale | 906 | $5.37 | $5K |
| 2026-03-06 | LONA | LeonaBio, Inc. | M — Option exercise | 3.9K | $0.00 | |
| 2025-06-30 | LONA | LeonaBio, Inc. | S — Open-market sale | 2.9K | $0.29 | $850 |
| 2025-06-30 | LONA | LeonaBio, Inc. | M — Option exercise | 12.4K | $0.00 | |
| 2025-06-30 | LONA | LeonaBio, Inc. | A — Grant or award | 10.0K | $0.23 | $2K |
Renninger Robert is a corporate insider — currently tracked as Insider. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($6K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Renninger Robert profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.